Alkermes (ALKS) Capital Expenditures (2010 - 2026)
Alkermes (ALKS) posted quarterly Capital Expenditures of $8.1 million for Q2 2026, down 37.42% year-over-year from $13.0 million in Q2 2025, and up 99.17% quarter-over-quarter from $4.1 million in Q1 2026.
Alkermes (ALKS) Capital Expenditures (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Capital Expenditures for 17 consecutive years, with $8.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 37.42% year-over-year to $8.1 million; the TTM figure through Jun 2026 stood at $29.5 million (down 28.25% YoY), while the FY2025 annual figure was $40.4 million, up 20.71% from the prior year.
- Capital Expenditures climbed to $8.1 million in Q2 2026 per ALKS's latest filing, from $4.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $17.3 million in Q3 2025 and bottomed at -$20000.0 in Q4 2025.
- Historically, Capital Expenditures has averaged $9.6 million across 5 years, with a median of $9.7 million in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 117.62% — and 2025, when it tumbled 100.2%.
- Alkermes' Capital Expenditures stood at $10.0 million in 2022, then surged by 69.82% to $17.0 million in 2023, then tumbled by 42.61% to $9.8 million in 2024, then plunged by 100.2% to -$20000.0 in 2025, then jumped by 40830.0% to $8.1 million in 2026.
- Business Quant data shows ALKS's Capital Expenditures at $8.1 million in Q2 2026, $4.1 million in Q1 2026, and -$20000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.50 Bn | 397.90 Mn | 8.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.15 Mn |
| Jun 30, 2026 | 8.15 Mn |
| Mar 31, 2026 | 4.09 Mn |
| Mar 31, 2026 | 4.09 Mn |
| Dec 31, 2025 | -20,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Sep 30, 2025 | 17.31 Mn |
| Sep 30, 2025 | 17.31 Mn |
| Jun 30, 2025 | 13.02 Mn |
| Jun 30, 2025 | 13.02 Mn |
| Mar 31, 2025 | 10.11 Mn |
| Mar 31, 2025 | 10.11 Mn |
| Dec 31, 2024 | 9.77 Mn |
| Dec 31, 2024 | 9.77 Mn |
| Sep 30, 2024 | 8.26 Mn |
| Sep 30, 2024 | 8.26 Mn |
| Jun 30, 2024 | 7.11 Mn |
| Jun 30, 2024 | 7.11 Mn |
| Mar 31, 2024 | 8.34 Mn |
| Mar 31, 2024 | 8.34 Mn |